Skip to main content

Table 2 Key product characteristics to be prioritized

From: Acceptance and perceived value of non-invasive malaria diagnostic tests in malaria-endemic countries

Product characteristic Priority Percentage*
Plasmodium spp. detection
  Pan/P. falciparum 40.0 %  
  P. falciparum/P. vivax 46.0 %  
Price per purpose   < $0.50 > $0.50
Saliva-based Largely replace both conventional RDTs and microscopy 32.00 % 0.76 %
  Largely replace conventional RDTs 41.00 % 17.42 %
Urine-based Largely replace both conventional RDTs and microscopy 16.90 % 5.16 %
  Largely replace conventional RDTs 25.35 % 15.02 %
Stability at 40 °C
  Absolutely essential 76.0 %  
  Probably not needed 1.0 %  
Ability to detect sub–microscopic infections
  Absolutely essential 74.0 %  
  Probably not needed 3.0 %  
Can be used by untrained lay people
  Absolutely essential 74.0 %  
  Probably not needed 1.0 %  
Shelf-life
24 month shelf–life Absolutely essential 66.0 %  
  Probably not needed 1.0 %  
18 month shelf–life Absolutely essential 43.0 %  
  Probably not needed 14.0 %  
Time to results: faster than current RDTs
  Absolutely essential 46.0 %  
  Probably not needed 9.0 %  
Quantitative results
  Absolutely essential 31.0 %  
  Probably not needed 10.0 %  
  1. Bold values “<0.50” and “>0.50” represent categories for which answers are given below (for instance 32% of respondant think that saliva based test will “largely replace conventional RDTs and microscopy”
  2. *Percentages do not add up to 100 because only the two most relevant options are presented here